Av. Brig. Faria Lima 2128 cj. 304
Jardim Paulista - São Paulo - SP
Clique para ver o mapa de acesso.
Tel. (11) 3812.0100

Hospital Israelita Albert Einstein
Av. Albert Einstein 627 - 12. andar
sala 1204-b Tel. (11) 37473204

Home

HPV na Prática Clínica

Conheça a clínica
Corpo clínico
Fale Conosco


Doenças e Disfunções
.Infertilidade
.Disfunção erétil
.Infecção urinária
.DST
.Próstata
.Rim
.Bexiga
.Testículos
.Pênis
.Cálculos urinários

.Vasectomia
.
Reversão de Vasectomia

Compre o livro
HPV na Prática Clínica



Mapa de acesso ao consultório

Infecção Urinária
  
Hematúria Microscópica (Tabelas)
 

TABLE 1


Risk Factors for Significant Disease
in Patients with Microscopic Hematuria


Smoking history
Occupational exposure to chemicals or dyes
(benzenes or aromatic amines)
History of gross hematuria
Age >40 years
History of urologic disorder or disease
History of irritative voiding symptoms
History of urinary tract infection
Analgesic abuse
History of pelvic irradiation


TABLE 3

Imaging Modalities for Evaluation of the Urinary Tract

Modality Advantages and disadvantages

Intravenous urography
Considered by many to be best initial study for evaluation of
urinary tract
Widely available and most cost-efficient in most centers
Limited sensitivity in detecting small renal masses
Cannot distinguish solid from cystic masses;therefore,
further lesion characterization by ultrasonography,computed
tomography or magnetic resonance imaging is necessary
Better than ultrasonography for detection of transitional cell
carcinoma in kidney or ureter
Ultrasonography

Excellent for detection and characterization of renal cysts
Limitations in detection of small solid lesions (<3 cm)

Computed tomography

Preferred modality for detection and characterization of solid
tomography renal masses
Detection rate for renal masses comparable to that of
magnetic resonance imaging,but more widely available
and less expensive
Best modality for evaluation of urinary stones,renal and
perirenal infections,and associated complications
Sensitivity of 94%to 98%for detection of renal stones,
compared with 52%to 59%for intravenous urography
and 19%for ultrasonography

TABLE 1
Substances and Medications Affecting Urine Color
Artificial food coloring
Beets
Berries
Chloroquine (Aralen)
Furazolidone (Furoxone)
Hydroxychloroquine (Plaquenil)
Nitrofurantoin (Furadantin)
Phenazopyridine (Pyridium)
Phenolphthalein
Rifampin (Rifadin)

 

TABLE 2
Mechanisms by Which Selected Drugs May Cause Hematuria
Mechanism Drugs
Interstitial nephritis Captopril (Capoten)
Cephalosporins
Chlorothiazide (Diuril)
Ciprofloxacin (Cipro)
Furosemide (Lasix)
NSAIDs
Olsalazine (Dipentum)
Omeprazole (Prilosec)
Penicillins
Rifampin (Rifadin)
Silver sulfadiazine (Silvadene)
Trimethoprim-sulfamethoxazole (Bactrim, Septra)
Papillary necrosis Acetylsalicylic acid (aspirin)
NSAIDs
Hemorrhagic cystitis Cyclophosphamide (Cytoxan)
Ifosfamide (Ifex)
Mitotane (Lysodren)
Urolithiasis Carbonic anhydrase inhibitors
Dichlorphenamide (Daranide)
Indinavir (Crixivan)
Mirtazapine (Remeron)
Ritonavir (Norvir)
Triamterene (Dyrenium)

 

TABLE 3
Glomerular and Nonglomerular Causes of Hematuria
Glomerular causes Nonglomerular causes

Primary glomerulonephritis

IgA nephropathy (Berger's disease) Postinfectious glomerulonephritis
Membranoproliferative glomerulonephritis
Focal glomerular sclerosis
Rapidly progressing glomerulonephritis

Secondary glomerulonephritis

Lupus nephritis
Henoch-Schönlein syndrome
Vasculitis (polyarteritis nodosa, Wegener's
granulomatosis)
Essential mixed cryoglobulinemia
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Medications (i.e., interstitial nephritis,
analgesic nephropathy)

Familial conditions

Thin glomerular basement membrane nephropathy
Hereditary nephritis (Alport's syndrome)
Fabry's disease

Exercise12-14

Conditions affecting renal parenchyma

Renal tumors (renal cell carcinoma, angiomyolipoma, oncocytoma)
Vascular disorders (nutcracker syndrome,15
malignant hypertension, sickle cell trait or disease,
arteriovenous malformation, renal vein thrombosis or infarct, transplant rejection)
Metabolic disorder (hypercalciuria, hyperuricuria)
Familial condition (polycystic kidney disease, medullary sponge kidney)
Infection (acute or chronic pyelonephritis,
tuberculosis, cytomegalovirus infection, infectious mononucleosis)
Papillary necrosis

Extrarenal conditions

Tumors (renal pelvis, ureter, bladder, prostate)
Benign prostatic hyperplasia
Stone or foreign body
Infections (cystitis, prostatitis, urinary schistosomiasis, tuberculosis, condyloma acuminatum)
Systemic bleeding disorder or coagulopathy
Trauma
Radiation therapy
Indwelling catheters
Drugs (heparin, warfarin [Coumadin], cyclophosphamide [Cytoxan])

 

TABLE 4
Physical Examination Findings and Associated Causes of Hematuria
Physical examination finding Cause of hematuria
General (systemic) examination
Severe dehydration Renal vein thrombosis
Peripheral edema Nephrotic syndrome, vasculitis
Cardiovascular system
Myocardial infarction Renal artery embolus or thrombus
Atrial fibrillation Renal artery embolus or thrombus
Hypertension Glomerulosclerosis with or without proteinuria
Abdomen
Bruit Arteriovenous fistula
Genitourinary system
Enlarged prostate Urinary tract infection
Phimosis Urinary tract infection
Meatal stenosis Urinary tract infection

 

TABLE 5
Risk Factors for Urothelial Carcinoma

Cigarette smoking
Occupational exposures

Aniline dyes
Aromatic amines
Benzidine

Dietary nitrites and nitrates
Analgesic abuse (e.g., phenacetin)
Chronic cystitis and bacterial infection associated with urinary calculi and obstruction of the upper urinary tract
Urinary schistosomiasis
Cyclophosphamide (Cytoxan)
Pelvic irradiation

 

TABLE 6
Risk Factors for Contrast Uropathy
Dehydration
Diabetes with azotemia
Cardiac decompensation
History of allergy
Asthma
Hay fever
Seafood allergy
Others, including allergic reactions to antibiotics
Previous reaction to contrast media
Renal insufficiency